As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends:1. Employer branding is becoming an increasingly important factor in the recruitment…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Joint Panel of Health, Science Ministries Wraps Up Talks on Ethics Code for Epidemiological, Clinical Research
May 2, 2014
-
REGULATORY Point-Based Calculations for Premiums Will Improve Predictability, Says Creator
May 1, 2014
-
BUSINESS Takeda, Teva to Commercialize Teva’s Parkinson’s Disease Treatment Rasagiline in Japan
April 30, 2014
-
ACADEMIA Chiba University to Advise Researchers to Retract Diovan Papers
April 28, 2014
-
REGULATORY MHLW Bureaucrats Think Chuikyo Will Spurn Annual Drug Price Revisions, Again
April 28, 2014
-
REGULATORY Chuikyo Subcommittee OKs Point-Based Premium Calculation Method, Adoption Scheduled in May
April 24, 2014
-
BUSINESS MTPC Names Masayuki Mitsuka as New President
April 24, 2014
-
BUSINESS Astellas Aims to Dominate SGLT-2 Inhibitor Market with Suglat
April 23, 2014
-
BUSINESS Lilly Japan Starts PIII Study of Tadalafil for DMD Treatment
April 22, 2014
-
REGULATORY MHLW Eyes 2 Year Transition for Electronic Data Submissions for New Drugs, Biosimilars
April 21, 2014
-
REGULATORY New Health Ministry Panel to Compile Report on Clinical Research Regulations by Autumn
April 18, 2014
-
REGULATORY Blue Letter on Xeplion Issued Following 21 Reported Deaths; Causal Relationship Remains Unclear
April 18, 2014
-
BUSINESS Sanofi Aims to Top SGLT-2 Inhibitor Market with Apleway
April 18, 2014
-
REGULATORY Govt Panel Members Pitch Yearly NHI Price Cut, 0.8 Trillion Yen Could’ve Been Pruned over 7 Years
April 17, 2014
-
BUSINESS Metal Found in Voltaren Product Again: Novartis
April 17, 2014
-
ORGANIZATION Funding for Investigator-Led Studies Should Be Based on Contracts: EFPIA Japan
April 16, 2014
-
BUSINESS FY2015 Recruitment Plan: Eisai to Resume Offering Jobs to New Graduates
April 15, 2014
-
BUSINESS Novartis Pharma Notified Police about Metal Object Found in Voltaren Product
April 15, 2014
-
ACADEMIA Public Hospitals Seeking to Avert Penalty Fee Cuts for Low Price Settlements
April 14, 2014
-
BUSINESS 10% of Valsartan Franchise Prescriptions Switched to Other ARBs, Azilva, Micamlo Top Lists
April 11, 2014
ページ
Novo Nordisk’s weight-loss medication Wegovy (semaglutide) was approved in Japan in March. While it skipped the May round of reimbursement listing, physicians eagerly await the arrival of what would be the first new obesity drug in three decades. Other companies…
Japan’s health ministry on April 27 presented an outline of a report to be compiled next month by its key…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…